Codexis rises after Q4 beat, strong outlook
Source: SeekingAlpha
2026-03-12 07:39:54 ET
More on Codexis
- Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
- Codexis outlines $72M–$76M 2026 revenue target as ECO Synthesis gains momentum and CDMO partnerships expand
- Seeking Alpha’s Quant Rating on Codexis
- Historical earnings data for Codexis
- Financial information for Codexis
Read the full article on Seeking Alpha
For further details see:
Codexis rises after Q4 beat, strong outlook
Codexis Inc.
NASDAQ: CDXS
CDXS Trading
3.52% G/L:
$2.50 Last:
728,058 Volume:
$2.44 Open:
CDXS Latest News
March 04, 2026 10:06:00 am
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing PlatformCDXS Stock Data
$116,066,832
79,756,430
0.15%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
